Home
Pascal Gelebart's picture

Pascal Gelebart

Researcher
  • E-mailPascal.Gelebart@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Lazarian, Gregory; Friedrich, Chloe; Quinquenel, Anne; Tran, Julie; Ouriemmi, Souhail; Dondi, Elisabeth; Martin, Antoine; Mihoub, Imane; Chiron, David; Bellanger, Céline; Fleury, Carole; Gelebart, Pascal; Mc Cormack, Emmet; Ledoux, Dominique; Thieblemont, Catherine; Marzec, Jacek; Gribben, John G.; Cymbalista, Florence; Varin-Blank, Nadine; Gardano, Laura; Baran-Marszak, Fanny. 2020. Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma. Oncogene.
  • Ladds, Marcus J.G.W.; van Leeuwen, Ingeborg M.M.; Drummond, Catherine J.; Chu, Su; Healy, Alan R.; Popova, Gergana; Pastor Fernández, Andrés; Mollick, Tanzina; Darekar, Suhas; Sedimbi, Saikiran K.; Nekulova, Marta; Sachweh, Marijke C.C.; Campbell, Johanna; Higgins, Maureen; Tuck, Chloe; Popa, Mihaela Lucia; Mayoral Safont, Mireia; Gelebart, Pascal; Fandalyuk, Zinayida; Thompson, Alastair M.; Svensson, Richard; Gustavsson, Anna-Lena; Johansson, Lars; Färnegårdh, Katarina; Yngve, Ulrika; Saleh, Aljona; Haraldsson, Martin; D'Hollander, Agathe C.A.; Franco, Marcela; Zhao, Yan; Håkansson, Maria; Walse, Björn; Larsson, Karin; Peat, Emma M.; Pelechano, Vicent; Lunec, John; Vojtesek, Borivoj; Carmena, Mar; Earnshaw, William C.; McCarthy, Anna R.; Westwood, Nicholas J.; Arsenian-Henriksson, Marie; Lane, David P.; Bhatia, Ravi; McCormack, Emmet; Laín, Sonia. 2018. A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications. 1-14.
  • Gelebart, Pascal; Popa, Mihaela Lucia; McCormack, Emmet. 2016. Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies. Current Pharmaceutical Biotechnology. 42-51.
Masters thesis
  • Gjerstad, May Eriksen. 2018. Preclinical development of novel therapeutics in mantle cell lymphoma.
  • Karlsen, Ida Tveit. 2017. Exploration of novel therapeutic options in mantle cell lymphoma.
Errata
  • Ladds, Marcus J.G.W.; van Leeuwen, Ingeborg M.M.; Drummond, Catherine J.; Chu, Su; Healy, Alan R.; Popova, Gergana; Pastor Fernández, Andrés; Mollick, Tanzina; Darekar, Suhas; Sedimbi, Saikiran K.; Nekulova, Marta; Sachweh, Marijke C.C.; Campbell, Johanna; Higgins, Maureen; Tuck, Chloe; Popa, Mihaela Lucia; Mayoral Safont, Mireia; Gelebart, Pascal; Fandalyuk, Zinayida; Thompson, Alastair M.; Svensson, Richard; Gustavsson, Anna-Lena; Johansson, Lars; Färnegårdh, Katarina; Yngve, Ulrika; Saleh, Aljona; Haraldsson, Martin; D'Hollander, Agathe C.A.; Franco, Marcela; Zhao, Yan; Håkansson, Maria; Walse, Björn; Larsson, Karin; Peat, Emma M.; Pelechano, Vicent; Lunec, John; Vojtesek, Borivoj; Carmena, Mar; Earnshaw, William C.; McCarthy, Anna R.; Westwood, Nicholas J.; Arsenian-Henriksson, Marie; Lane, David P.; Bhatia, Ravi; McCormack, Emmet; Laín, Sonia. 2018. Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications.

More information in national current research information system (CRIStin)